1003-3734
2012 Issue 7
Anti-endotoxin effcet of Swertia macrosperma C.B. Clark
XIONG Cheng-wen1;SUN Bo2;XING Wei-wei3;JIA Yan-hua4
XIONG Cheng-wen1;SUN Bo2;XING Wei-wei3;JIA Yan-hua4
..............page:788-790
Current situation and development of the quality standard research of traditional Chinese medicine
XIN Min-tong1;LI Zheng1;GUO Hong-zhu1;DONG Run-sheng2;WANG Zhi-bin1
XIN Min-tong1;LI Zheng1;GUO Hong-zhu1;DONG Run-sheng2;WANG Zhi-bin1
..............page:710-713
Efficacy of extended release paliperidone at flexible-dose and its influence on glucose and lipid metabolism in patients with acute schizophrenia
WU Feng-chun;NING Yu-ping;LI Zhuo-li;LU Wei-cong
WU Feng-chun;NING Yu-ping;LI Zhuo-li;LU Wei-cong
..............page:772-775
Information management in clinical trials
DING Qian1;CAO Cai2
DING Qian1;CAO Cai2
..............page:722-727
Research status and trends of pseudostellariae radix
FU Xing-sheng;LIU Xun-hong;XU Hu;ZHOU Yi-zhi;CHEN Fei
FU Xing-sheng;LIU Xun-hong;XU Hu;ZHOU Yi-zhi;CHEN Fei
..............page:757-760
Effect of jolkinolide B on apoptosis of breast cancer Bcap37 cells
LIN Yu1;2;CUI Hong-xia1;XU Hui-yu1;ZHOU Li1;NIU Ying-cai1;LIU Ji-cheng1
LIN Yu1;2;CUI Hong-xia1;XU Hui-yu1;ZHOU Li1;NIU Ying-cai1;LIU Ji-cheng1
..............page:780-783
2011 nian mei guo fda pi zhun de xin yao
shi zuo zuo feng yu fei
shi zuo zuo feng yu fei
..............page:703-705,709
Meta-analysis of C677T genetic polymorphism in methylenetetra-hydrofolate reductase in Chinese and acute lymphoblastic leukemia
LIU En-yi1;2;HUANG Lin1;ZHAO Li-bo1;LIU Yi1;YANG Wei2;LI Yu-zhen1
LIU En-yi1;2;HUANG Lin1;ZHAO Li-bo1;LIU Yi1;YANG Wei2;LI Yu-zhen1
..............page:808-813
Study on intestinal absorption of clematichinenoside AR in rats by in-situ single-pass perfusion model
WANG Da-wei1;2;ZHANG Ji1;LI Pei1;LI Feng1;LIU Xiao-dong1
WANG Da-wei1;2;ZHANG Ji1;LI Pei1;LI Feng1;LIU Xiao-dong1
..............page:800-803
Introducing internationally recognized management method in Chinese clinical trial institution
WANG Tian-xun1;MAO Yi-min2;GONG Yan-hua3;LIANG Wen-juan1
WANG Tian-xun1;MAO Yi-min2;GONG Yan-hua3;LIANG Wen-juan1
..............page:728-731
Flavonoid glycosides in buds of Jasminum officinale var. grandiflorum
ZHAO Gui-qin;MAO Xiao-xia;SU Zhan-hui
ZHAO Gui-qin;MAO Xiao-xia;SU Zhan-hui
..............page:791-794
..............page:775
..............page:701-702
The effects of chimonin on superoxide dismutase and malondialdehyde in heart and liver tissues in chronic hypoxia-hypercapnia rats
FAN Rong;LU Yuan-yuan;HUANG Xiao-ying;WANG Liang-xing
FAN Rong;LU Yuan-yuan;HUANG Xiao-ying;WANG Liang-xing
..............page:804-807
Guideline on missing data in confirmatory clinical trials
CHEN Yuan-cheng;ZHANG Jing
CHEN Yuan-cheng;ZHANG Jing
..............page:732-736,766
Regulatory perspective on the importance of safety pharmacology study before clinical trial of new drugs
WANG Yu-zhu;WANG Qing-li
WANG Yu-zhu;WANG Qing-li
..............page:718-721
Measurement and transformation of utilities for health states worse than death
WU Hong-yan;SUN Li-hua
WU Hong-yan;SUN Li-hua
..............page:714-717
Research progress of ascorbyl glucoside derivates
RAO Jian-hua;HAN Lu;ZHANG Zi-ping
RAO Jian-hua;HAN Lu;ZHANG Zi-ping
..............page:761-766
Risperidone-loaded long-acting injectable microspheres prepared by ultra-fine particle processing system
FU Han1;2;WEN Xin-guo1;WANG Zhou-hua1;PAN Xin1;WU Chuan-bin1;2
FU Han1;2;WEN Xin-guo1;WANG Zhou-hua1;PAN Xin1;WU Chuan-bin1;2
..............page:795-799
Simultaneous determination of ascaridole,p-cymene and α-terpinene in Jinghua Weikang Jiaowan by GC
ZHU Yong-hong1;2;LI Wei2;HAN Jian-ping2;CHU Yang2;WANG Xiang-yang2
ZHU Yong-hong1;2;LI Wei2;HAN Jian-ping2;CHU Yang2;WANG Xiang-yang2
..............page:737-739
Research progress in drug interaction between proton-pump inhibitors and clopidogrel
DANG Guo-hong1;LIU Zhi-jun2
DANG Guo-hong1;LIU Zhi-jun2
..............page:751-756
Roles of clinical pharmacists in prophylactic use of antibiotics during perioperative period in department of general surgery
SHI Tian-lu1;JIANG Ling1;SUN Yan-cai1;WU Ying-qi1;HUANG Qiang2
SHI Tian-lu1;JIANG Ling1;SUN Yan-cai1;WU Ying-qi1;HUANG Qiang2
..............page:814-818
In vitro anti-HIV-1 activities of resveratrol derivatives
HAUNG Ning1;3;YANG Liu-meng1;WANG Rui-rui1;ZHU Hai-liang2;ZHENG Yong-tang1
HAUNG Ning1;3;YANG Liu-meng1;WANG Rui-rui1;ZHU Hai-liang2;ZHENG Yong-tang1
..............page:740-745
Enhancement of TAT cell membrane penetration efficiency by polyvinylpyrrolidone
MA Jie-lan;ZHANG Jie;ZHANG Qiu-ling;LIU Chang-bai
MA Jie-lan;ZHANG Jie;ZHANG Qiu-ling;LIU Chang-bai
..............page:784-787,822
Preliminary analysis of cytokine-release syndrome induced by monoclonal antibodies
LIN Zhi1;2;Lü Jian-jun1;QU Zhe1;GENG Xing-chao1;YANG Yan-wei1;ZHANG Di1;LI Shan-shan1;LI Bo1
LIN Zhi1;2;Lü Jian-jun1;QU Zhe1;GENG Xing-chao1;YANG Yan-wei1;ZHANG Di1;LI Shan-shan1;LI Bo1
..............page:746-750,756
Introduction and evaluation of Bayesian adaptive randomization in clinical trials
CHEN Dong1;XIA Jie-lai1;JIANG Zhi-wei1;WANG Yong-ji2
CHEN Dong1;XIA Jie-lai1;JIANG Zhi-wei1;WANG Yong-ji2
..............page:706-709
Docetaxel,oxaliplatin and 5-fluorouracil combination chemotherapy in 41 patients with advanced gastric cancer
ZHANG Miao-miao;WANG Xing-yuan;XING Pu-yuan;FENG Feng-yi
ZHANG Miao-miao;WANG Xing-yuan;XING Pu-yuan;FENG Feng-yi
..............page:767-771
The general pharmacology of rhIFNα 2a-NGR,a target-therapy candidate for cancer
ZHANG Bao-lai1;2;DONG Shu-hong1;LIU Xia1;LU Li1;CUI Ming-xia1; WANG Li1;ZHANG Ying-qi3;WU Yong-jie1
ZHANG Bao-lai1;2;DONG Shu-hong1;LIU Xia1;LU Li1;CUI Ming-xia1; WANG Li1;ZHANG Ying-qi3;WU Yong-jie1
..............page:776-779,794
Literature analysis of adverse drug reactions induced by ambroxol hydrochloride
XIA Zhong-ni;YING Yin;SUN Yun-feng;SHI Jia-na
XIA Zhong-ni;YING Yin;SUN Yun-feng;SHI Jia-na
..............page:819-822